PBRM1 and neoplasm: KEGG pathway analysis showed that gene sets related to p53 pathway were significantly enriched among genes up-regulated in PBRM1-deficient cells compared to 786-O control cells treated with Fdcyd (Figures 3A, B), suggesting that tumor cell death under Fdcyd treatment may due to the activation of p53 signaling pathway.